Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Lorch Named New Pfizer Chairman

December 14, 2010 4:53 am | News | Comments

Drug developer Pfizer Inc. said that it named George A. Lorch as its new chairman of the board of directors, one week following the abrupt resignation of CEO Jeffrey B. Kindler.


Knock-In Rat

December 13, 2010 8:30 am | Product Releases | Comments

Sigma Life Science announced that its SAGE Labs initiative has successfully used its proprietary CompoZr Zinc Finger Nuclease technology to generate knock-in rats in which foreign genes have been inserted.


Volumetric Titrator

December 13, 2010 8:27 am | Product Releases | Comments

JM Science announces their AQUACOUNTER Karl Fischer Volumetric Titrator. This high-end titrator has a very wide range from 100 ppm to 100% water content with is maximum capability for automation and future up-gradability.


Stem Cells Turned Into Functioning Intestinal Tissue

December 13, 2010 6:22 am | News | Comments

For the first time, scientists have created functioning human intestinal tissue in the laboratory from pluripotent stem cells. Researchers say their findings will open the door to unprecedented studies of human intestinal development, function and disease.


New Way to Produce ZFNs Found

December 13, 2010 6:18 am | News | Comments

A team led by Massachusetts General Hospital researchers has developed a faster way to engineer synthetic enzymes that target specific DNA sequences for inactivation, repair or alteration.


MorphoSys Signs Deal with Pfizer

December 13, 2010 6:08 am | News | Comments

MorphoSys AG announced the signing of a non-exclusive license and technology transfer agreement between its subsidiary Sloning BioTechnology GmbH and Pfizer. The agreement covers the installation, training and use of Sloning's technology platform Slonomics.


Merck Announces Two New Board Members

December 13, 2010 6:04 am | News | Comments

Merck KGaA announced that Dr. Stefan Oschmann will become a member of the Executive Board and General Partner of Merck KGaA. Dr. Kai Beckmann will become a member of the Executive Board and General Partner of Merck KGaA effective April 1, 2011.


Amgen Releases XGEVA Study Data

December 13, 2010 5:58 am | News | Comments

Amgen announced results from new analyses comparing XGEVA (denosumab), the first new treatment for advanced cancer patients with bone metastases in nearly a decade to prevent skeletal-related events, to Zometa (zoledronic acid).


ImmunoGen Presents T-DM1 Data

December 13, 2010 5:42 am | News | Comments

ImmunoGen, Inc., a biopharmaceutical company that develops anticancer therapeutics using its Targeted Antibody Payload technology, presented the first clinical data for trastuzumab-DM1 used in combination with pertuzumab for HER2+ metastatic breast cancer.


Valeant Chairman Wells Resigns

December 13, 2010 5:35 am | News | Comments

Valeant Pharmaceuticals International Inc. said that Chairman Bill Wells resigned from the board to pursue other interests. The change comes as Valeant deals with setbacks for two of its most advanced drug candidates.


Sanofi Extends $18.5B Takeover Bid

December 13, 2010 5:32 am | News | Comments

French pharmaceutical group Sanofi-Aventis said it has extended its unsolicited $18.5 billion takeover offer for U.S.-based biotech company Genzyme.


PharmaNet Adds Two Technology Platforms

December 13, 2010 5:29 am | News | Comments

PharmaNet Development Group, Inc. is launching two technology platforms—Initiator and PKS—that will provide improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase 1 clinics.


Gas Control Module

December 10, 2010 6:36 am | Product Releases | Comments

Tecan has launched a gas control module for its Infinite 200 PRO multimode microplate reader, creating one of the most comprehensive solutions on the market for cell-based assays.


Knock-Out Rat

December 10, 2010 6:32 am | Product Releases | Comments

Taconic and Transposagen Biopharmaceuticals have entered into a non-exclusive marketing and distribution agreement for Taconic to produce and distribute Transposagen’s FatRat.


WIL Research Hires New CIO And CCO

December 10, 2010 6:23 am | News | Comments

WIL Research Company, Inc., a global Contract Research Organization and leading provider of drug development services, appointed Howard Moody as chief information officer and Alan Findlater as chief commercial officer.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.